Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
103studies shown
Showing 73-84 of 103
Drug study icon
CompletedNCT01072630

Armodafinil Treatment for depression

This study is completed in the United States, in Australia, in France, .... It is testing armodafinil Treatment for depression.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Cephalon
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00868959

Lurasidone - A 24-week Extension Study of people with Bipolar I Depression

This study exists to explore whether the medication Patients could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States, France, Canada, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00868452

Lurasidone - A 6-week Study of people with Bipolar I Depression (Add-on)

This study exists to explore whether the medication Patients could improve care and understanding. Researchers are trying to understand what the medication Patients could change in day-to-day care and decision-making.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States, France, Czechia, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00868699

Lurasidone - A 6-week Study of people with Bipolar I Depression (Monotherapy)

This study exists to explore whether the medication Patients could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States, France, Czechia, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT02046369

Lurasidone Pediatric Bipolar Study

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 10 Years to 17 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Behavioral study icon
CompletedNCT03630822

Comparative and Prospective Study Evaluating the Impact on the Care Path of an Editorial Program Accompanied by Advance Directives in Psychiatry (DAP) for People Suffering From Schizophrenia, Bipolarity type I or Schizoaffective Disorder

This study is completed in France. It focuses on schizophrenia.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaBehavioralOver 18 Years
Countries
France
Sponsor
Assistance Publique Hopitaux De Marseille
Condition
Bipolarity, Schizophrenia
Device study icon
CompletedNCT01644747

tDCS as an add-on Treatment for Resistant Major Depression in Uni- or Bipolar Patients

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Besancon
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2008-007483-42

Lurasidone for depression

This study is completed in France, in Czechia, in Germany, .... It is testing lurasidone for depression.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionOther
Countries
France, Czechia, Germany, ...
Sponsor
Sunovion Pharmaceuticals Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2008-007457-13

Lurasidone for depression

This study is completed in France, in Czechia, and in Germany. It is testing lurasidone for depression.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionOther
Countries
France, Czechia, Germany
Sponsor
Sunovion Pharmaceuticals, Inc.
Condition
Bipolarity, Depression
Drug study icon
TerminatedEUCTR 2013-004903-37

LURASIDONE for Bipolarity

This study was terminated in France, in the United Kingdom, in Italy, .... It is testing LURASIDONE for Bipolarity.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionOther
Countries
France, United Kingdom, Italy, ...
Sponsor
SUNOVION PHARMACEUTICALS INC.
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2008-007482-23

Lurasidone Adjunctive to Lithium or Divalproex for depression

This study is completed in France, in Czechia, and in Germany. It is testing lurasidone Adjunctive to Lithium or Divalproex for depression.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionOther
Countries
France, Czechia, Germany
Sponsor
Sunovion Pharmaceuticals, Inc.
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.